These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8818241)

  • 1. Synthesis of five enantiomerically pure haptens designed for in vitro evolution of antibodies with peptidase activity.
    Wagner J; Lerner RA; Barbas CF
    Bioorg Med Chem; 1996 Jun; 4(6):901-16. PubMed ID: 8818241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens.
    Odenbaugh AL; Helms ED; Iverson BL
    Bioorg Med Chem; 2000 Feb; 8(2):413-26. PubMed ID: 10722164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach to sequence-specific antibody proteases. The use of haptens mimicking both a transition state and a distorted ground state.
    Smith RM; Yuan P; Weiner DP; Dutton CR; Hansen DE
    Appl Biochem Biotechnol; 1994; 47(2-3):329-42; discussion 342-3. PubMed ID: 7944347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remarkable remote chiral recognition in a reaction mediated by a catalytic antibody.
    D'Souza LJ; Gigant B; Knossow M; Green BS
    J Am Chem Soc; 2002 Mar; 124(10):2114-5. PubMed ID: 11878955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic antibody route to the naturally occurring epothilones: total synthesis of epothilones A-F.
    Sinha SC; Sun J; Miller GP; Wartmann M; Lerner RA
    Chemistry; 2001 Apr; 7(8):1691-702. PubMed ID: 11349910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward the antibody-catalyzed chemiluminescence. Design and synthesis of hapten.
    Sawa M; Imaeda Y; Hiratake J; Fujii R; Umeshita R; Watanabe M; Kondo H; Oda J
    Bioorg Med Chem Lett; 1998 Mar; 8(6):647-52. PubMed ID: 9871576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine catalytic antibodies: the primary importance of linker effects.
    Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD
    Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of the hapten for the induction of antibodies catalyzing aldol reaction.
    Teraishi K; Saito M; Fujii I; Nakamura H
    J Mol Graph; 1994 Dec; 12(4):282-5, 292. PubMed ID: 7696219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple reactive immunization towards the hydrolysis of organophosphorus nerve agents: hapten design and synthesis.
    Huang H; Han WG; Noodleman L; Grynszpan F
    Bioorg Med Chem; 2001 Dec; 9(12):3185-95. PubMed ID: 11711294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural convergence in the active sites of a family of catalytic antibodies.
    Charbonnier JB; Golinelli-Pimpaneau B; Gigant B; Tawfik DS; Chap R; Schindler DG; Kim SH; Green BS; Eshhar Z; Knossow M
    Science; 1997 Feb; 275(5303):1140-2. PubMed ID: 9027317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A class of 4-aza-lithocholic acid-derived haptens for the generation of catalytic antibodies with steroid synthase capabilities.
    Hasserodt J; Janda KD; Lerner RA
    Bioorg Med Chem; 2000 May; 8(5):995-1003. PubMed ID: 10882011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphonate analogues of carboxypeptidase A substrates are potent transition-state analogue inhibitors.
    Hanson JE; Kaplan AP; Bartlett PA
    Biochemistry; 1989 Jul; 28(15):6294-305. PubMed ID: 2790000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in hydrolytic antibody activity by change in haptenic structure from phosphate to phosphonate with retention of a common leaving-group determinant: evidence for the 'flexibility' hypothesis.
    Gul S; Sonkaria S; Pinitglang S; Florez-Alvarez J; Hussain S; Thomas EW; Ostler EL; Gallacher G; Resmini M; Brocklehurst K
    Biochem J; 2003 Dec; 376(Pt 3):813-21. PubMed ID: 12946271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
    Tantillo DJ; Houk KN
    J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate antibody catalysis.
    Gololobov G; Sun M; Paul S
    Mol Immunol; 1999 Dec; 36(18):1215-22. PubMed ID: 10684961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of chiral and racemic phosphonate-based haptens for the induction of aldolase catalytic antibodies.
    Mu YQ; Gibbs RA
    Bioorg Med Chem; 1997 Jul; 5(7):1327-37. PubMed ID: 9377093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large rate accelerations in antibody catalysis by strategic use of haptenic charge.
    Thorn SN; Daniels RG; Auditor MT; Hilvert D
    Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten.
    Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS
    Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody catalysis via strategic use of haptenic charge.
    Kikuchi K; Hilvert D
    Acta Chem Scand (Cph); 1996 Apr; 50(4):333-6. PubMed ID: 8639376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide synthesis catalyzed by an antibody containing a binding site for variable amino acids.
    Hirschmann R; Smith AB; Taylor CM; Benkovic PA; Taylor SD; Yager KM; Sprengeler PA; Benkovic SJ
    Science; 1994 Jul; 265(5169):234-7. PubMed ID: 8023141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.